FDA Strongly Warns Against 'Microdosing' Chocolate Bars

The Food and Drug Administration (FDA) is warning consumers about a mushroom-infused chocolate bar that has reportedly sent some people to the hospital.

The FDA issued an advisory on June 7 regarding Diamond Shruumz's “microdosing” of chocolate bars. The chocolate bars contain a “proprietary nootropic blend” that, according to its website, is said to provide a “relaxing euphoric experience without psilocybin.”

“The FDA and CDC, in collaboration with the U.S. Poison Centers and state and local partners, are investigating a range of illnesses associated with eating Diamond Shruumz brand Microdosing Chocolate Bars,” according to the FDA website.

“Do not eat, sell or serve Diamond Shruumz brand Microdosing Chocolate Bars,” the site warns. “The FDA investigation is ongoing.”

STUDY FINDS EVIDENCE OF MICROPLASTICS IN BRAIN AND OTHER ORGANS

The FDA is warning consumers about Diamond Shruumz chocolate bars. (FDA | iStock)

“Microdosing” is a practice of taking a very small amount of psychedelic drugs with the intention of increasing productivity, boosting creativity, and improving mood. According to Diamond Shruumz's website, the brand said its products help achieve “a subtle, lush experience and a more creative state of mind.”

“We are talking about treats with a kick,” says the brand. “So if you like mushroom chocolate bars and want to try some microdosing, come check us out. We might just change the way you see the world.”

But government officials warn that the products have caused seizures in some consumers and vomiting in others.

“People who became ill after eating Diamond Shruumz brand Microdosing Chocolate Bars reported a variety of serious symptoms, including seizures, central nervous system depression (loss of consciousness, confusion, drowsiness), agitation, abnormal heart rate, hyper/hypotension, nausea and vomiting,” the FDA reported.

WOMAN LEFT WITH KIDNEY DAMAGE AFTER VISITING HAIRDRESSER

Six people reportedly experienced such severe reactions that they sought medical attention.

Split image of a woman eating chocolate and a woman clenching her stomach in pain

At least eight people have suffered various medical symptoms, including nausea, from the chocolates. (iStock)

“All eight people reported seeking medical care; six were hospitalized,” the FDA news release said. “No deaths have been reported.”

Diamond Shruumz says on its website that its products are not necessarily psychedelic. Although the chocolate is marketed as promising a psilocybin-like experience, it does not contain psilocybin.

“There is no presence of psilocybin, amanita or other scheduled drugs, ensuring a safe and enjoyable experience,” the website claims. “Rest assured, our treats are not only psychedelic-free, but our carefully crafted ingredients still deliver an experience.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“This allows you to enjoy a uniquely crafted blend designed for your enjoyment and peace of mind.”

Officials are warning consumers to keep the products out of the reach of minors because children and teens may be tempted to eat the chocolate bars.

Woman eating chocolate

The chocolate bars are marketed as products that boost mood and creativity. (iStock)

“This product may appeal to children and teenagers because it is marketed as a candy,” the FDA advises. “Parents and caregivers should consider discussing the information in this advice with their children and take extra care to avoid this product being consumed by younger people.”

The FDA and CDC are actively investigating the products.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Fox News Digital reached out to Diamond Shruumz for comment but did not hear back.

For more health articles, visit www.foxnews.com/health.

Related Posts

  • Health
  • June 15, 2024
  • 4 views
  • 2 minutes Read
Honey bees can detect lung cancer in humans: study

(NewsNation) — Bad breath can say a lot about you. But soon it could help determine if you have lung cancer — or if a honeybee gets a whiff. Researchers…

  • Health
  • June 14, 2024
  • 4 views
  • 3 minutes Read
Sanders drops the subpoena after Novo Nordisk CEO agrees to testify

Sen. Bernie Sanders (I-Vt.) on Friday halted his search for a subpoena for a top pharmaceutical executive after the company's CEO agreed to testify before the Senate later this year.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

New Jersey Senator Bob Menendez's strategy to blame his wife in a bribery trial could have pitfalls

  • June 15, 2024
New Jersey Senator Bob Menendez's strategy to blame his wife in a bribery trial could have pitfalls

FTC Chair Lina Khan on Startups, Scaling and 'Innovations in the Field of Possible Law Violations'

  • June 15, 2024
FTC Chair Lina Khan on Startups, Scaling and 'Innovations in the Field of Possible Law Violations'

Following a routine makes it easier to build wealth. Here's how

  • June 15, 2024
Following a routine makes it easier to build wealth.  Here's how

Investors are wondering whether technology can continue to lift the S&P 500 to new records this summer

  • June 15, 2024
Investors are wondering whether technology can continue to lift the S&P 500 to new records this summer

New research approach: investigating the mouthfeel of food with a microscope

  • June 15, 2024
New research approach: investigating the mouthfeel of food with a microscope

Salesforce (CRM) Q1 2025 Earnings Report

  • June 15, 2024
Salesforce (CRM) Q1 2025 Earnings Report

Quantum entanglement measures the rotation of the Earth

  • June 15, 2024
Quantum entanglement measures the rotation of the Earth

DOJ Destroys GOP Conspiracy That Controlled New York Trial

  • June 15, 2024
DOJ Destroys GOP Conspiracy That Controlled New York Trial

Nvidia's 'Nemotron-4 340B' model redefines synthetic data generation and competes with GPT-4

  • June 15, 2024
Nvidia's 'Nemotron-4 340B' model redefines synthetic data generation and competes with GPT-4

China needs bond market reforms to rein in rising debt, S&P Global says

  • June 15, 2024
China needs bond market reforms to rein in rising debt, S&P Global says

The tasty flavors of chocolate can pose a risk in other desserts

  • June 15, 2024
The tasty flavors of chocolate can pose a risk in other desserts